Your browser is no longer supported. Please, upgrade your browser.
MRNA [NASD]
Moderna, Inc.
IndexS&P 500 P/E20.24 EPS (ttm)16.28 Insider Own1.90% Shs Outstand404.00M Perf Week31.11%
Market Cap127.38B Forward P/E12.52 EPS next Y26.32 Insider Trans-15.12% Shs Float366.79M Perf Month-3.30%
Income7.06B PEG1.20 EPS next Q6.46 Inst Own61.20% Short Float3.55% Perf Quarter-13.76%
Sales11.83B P/S10.77 EPS this Y-26.10% Inst Trans6.09% Short Ratio1.00 Perf Half Y78.17%
Book/sh25.06 P/B13.15 EPS next Y2.17% ROA49.50% Target Price304.92 Perf Year201.91%
Cash/sh23.05 P/C14.30 EPS next 5Y16.80% ROE121.60% 52W Range98.65 - 497.49 Perf YTD215.53%
Dividend- P/FCF11.19 EPS past 5Y- ROI-28.40% 52W High-33.74% Beta-
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin85.90% 52W Low234.14% ATR21.98
Employees1300 Current Ratio1.30 Sales Q/Q6398.50% Oper. Margin64.30% RSI (14)61.68 Volatility7.17% 6.02%
OptionableYes Debt/Eq0.05 EPS Q/Q- Profit Margin59.70% Rel Volume2.86 Prev Close273.39
ShortableYes LT Debt/Eq0.02 EarningsNov 04 BMO Payout0.00% Avg Volume12.95M Price329.63
Recom2.70 SMA2020.47% SMA501.14% SMA20027.96% Volume35,901,208 Change20.57%
Nov-09-21Initiated Wolfe Research Outperform $304
Oct-22-21Initiated Deutsche Bank Sell $250
Oct-15-21Upgrade Piper Sandler Neutral → Overweight $445
Aug-06-21Downgrade Piper Sandler Overweight → Neutral $246 → $445
Aug-06-21Downgrade Oppenheimer Outperform → Perform
Jul-15-21Reiterated Jefferies Hold $170 → $250
Feb-01-21Downgrade BofA Securities Neutral → Underperform
Dec-16-20Downgrade Morgan Stanley Overweight → Equal-Weight $150
Dec-16-20Downgrade Jefferies Buy → Hold $90 → $150
Dec-09-20Downgrade Needham Buy → Hold
Nov-23-20Initiated Wells Fargo Equal Weight $92
Nov-17-20Downgrade BMO Capital Markets Outperform → Market Perform $109
Sep-08-20Downgrade SVB Leerink Mkt Perform → Underperform $58 → $41
Jul-23-20Initiated SVB Leerink Mkt Perform
Jul-20-20Downgrade JP Morgan Overweight → Neutral $89
Jul-13-20Initiated Jefferies Buy $90
Jun-30-20Initiated Argus Buy $80
Jun-08-20Initiated Barclays Overweight $68
Apr-30-20Initiated BMO Capital Markets Outperform $83
Mar-05-20Downgrade BofA/Merrill Buy → Neutral $32
Nov-28-21 10:19PM  
06:30PM  
02:58PM  
10:30AM  
04:34AM  
Nov-26-21 08:57PM  
05:32PM  
03:56PM  
03:31PM  
02:13PM  
02:09PM  
01:32PM  
01:24PM  
01:06PM  
11:40AM  
11:14AM  
10:53AM  
10:40AM  
10:23AM  
09:42AM  
09:30AM  
09:27AM  
09:24AM  
09:17AM  
07:30AM  
07:20AM  
07:15AM  
07:13AM  
06:54AM  
03:42AM  
Nov-25-21 08:56AM  
Nov-24-21 04:55PM  
11:21AM  
11:08AM  
11:00AM  
07:00AM  
06:30AM  
05:55AM  
Nov-23-21 04:30PM  
01:00PM  
12:17PM  
11:55AM  
11:31AM  
10:26AM  
08:20AM  
05:52AM  
Nov-22-21 04:20PM  
03:25PM  
02:14PM  
12:29PM  
11:12AM  
10:35AM  
10:21AM  
10:02AM  
08:30AM  
08:12AM  
07:03AM  
05:08AM  
04:38AM  
Nov-21-21 12:07PM  
09:01AM  
06:30AM  
Nov-20-21 07:09PM  
06:40AM  
Nov-19-21 06:42PM  
06:29PM  
06:03PM  
05:03PM  
04:37PM  
04:22PM  
04:13PM  
04:06PM  
03:58PM  
03:52PM  
02:30PM  
12:32PM  
11:50AM  
11:31AM  
11:13AM  
11:00AM  
10:42AM  
09:26AM  
09:03AM  
08:53AM  
08:39AM  
08:37AM  
08:29AM  
08:07AM  
08:07AM  
06:00AM  
03:42AM  
01:09AM  
Nov-18-21 08:03PM  
01:56PM  
12:20PM  
08:20AM  
07:52AM  
07:00AM  
Nov-17-21 06:08PM  
04:04PM  
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group for fill-finish manufacturing of its COVID-19 vaccine candidate, as well as Aldevron, LLC for supporting COVID-19 vaccine and additional programs in company's clinical development pipeline. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andres JuanSee remarksNov 24Option Exercise12.215,00061,0505,000Nov 26 02:08 PM
Bancel StephaneChief Executive OfficerNov 24Sale273.019,0002,457,0905,940,868Nov 26 01:59 PM
Andres JuanSee remarksNov 24Sale273.015,0001,365,0500Nov 26 02:08 PM
Hoge StephenPresidentNov 23Option Exercise4.2915,00064,4001,624,597Nov 26 02:20 PM
Hoge StephenPresidentNov 23Sale275.5215,0004,132,7721,609,597Nov 26 02:20 PM
Andres JuanSee remarksNov 22Option Exercise13.5515,000203,25015,000Nov 23 06:16 PM
Andres JuanSee remarksNov 22Sale268.1815,0004,022,7000Nov 23 06:16 PM
Andres JuanSee remarksNov 19Option Exercise12.215,00061,0505,000Nov 23 06:16 PM
Andres JuanSee remarksNov 19Sale265.715,0001,328,5500Nov 23 06:16 PM
Bancel StephaneChief Executive OfficerNov 18Sale245.8910,0002,458,9007,144,880Nov 19 04:09 PM
Andres JuanSee remarksNov 17Option Exercise12.215,00061,0505,000Nov 19 04:15 PM
Bancel StephaneChief Executive OfficerNov 17Sale234.579,0002,111,1305,953,868Nov 19 04:09 PM
Andres JuanSee remarksNov 17Sale234.575,0001,172,8500Nov 19 04:15 PM
Andres JuanSee remarksNov 15Option Exercise12.215,00061,0505,000Nov 16 04:23 PM
Hoge StephenPresidentNov 15Option Exercise4.2915,00064,4001,624,597Nov 16 04:25 PM
Andres JuanSee remarksNov 15Sale231.015,0001,155,0500Nov 16 04:23 PM
Hoge StephenPresidentNov 15Sale231.0115,0003,465,1501,609,597Nov 16 04:25 PM
Andres JuanSee remarksNov 12Option Exercise12.215,00061,0505,000Nov 16 04:23 PM
Hoge StephenPresidentNov 12Option Exercise10.905,00054,5001,614,597Nov 16 04:25 PM
Andres JuanSee remarksNov 12Sale225.865,0001,129,3000Nov 16 04:23 PM
Hoge StephenPresidentNov 12Sale225.865,0001,129,3001,609,597Nov 16 04:25 PM
Bancel StephaneChief Executive OfficerNov 11Sale227.6710,0002,276,7007,154,880Nov 12 04:07 PM
Andres JuanSee remarksNov 10Option Exercise12.215,00061,0505,000Nov 12 04:16 PM
Bancel StephaneChief Executive OfficerNov 10Sale230.009,0002,070,0005,996,868Nov 12 04:07 PM
Andres JuanSee remarksNov 10Sale230.005,0001,150,0000Nov 12 04:16 PM
Andres JuanSee remarksNov 08Option Exercise13.5515,000203,25015,000Nov 09 04:36 PM
Andres JuanSee remarksNov 08Sale233.1315,0003,496,9500Nov 09 04:36 PM
Andres JuanSee remarksNov 05Option Exercise12.215,00061,0505,000Nov 09 04:36 PM
Andres JuanSee remarksNov 05Sale240.005,0001,200,0000Nov 09 04:36 PM
Bancel StephaneChief Executive OfficerNov 04Sale295.5010,0002,955,0007,164,880Nov 05 05:04 PM
Hoge StephenPresidentNov 03Option Exercise0.9910,0009,9001,619,597Nov 04 04:43 PM
Andres JuanSee remarksNov 03Option Exercise12.215,00061,0505,000Nov 05 05:09 PM
Hoge StephenPresidentNov 03Sale350.0010,0003,500,0001,609,597Nov 04 04:43 PM
Bancel StephaneChief Executive OfficerNov 03Sale350.009,0003,150,0006,009,868Nov 05 05:04 PM
Andres JuanSee remarksNov 03Sale350.005,0001,750,0000Nov 05 05:09 PM
Hoge StephenPresidentNov 02Option Exercise0.9910,0009,9001,619,597Nov 04 04:43 PM
Hoge StephenPresidentNov 02Sale338.5410,0003,385,4001,609,597Nov 04 04:43 PM
Andres JuanSee remarksNov 01Option Exercise12.215,00061,0505,000Nov 02 04:16 PM
Andres JuanSee remarksNov 01Sale335.005,0001,675,0000Nov 02 04:16 PM
Andres JuanSee remarksOct 29Option Exercise12.215,00061,0505,000Nov 02 04:16 PM
Andres JuanSee remarksOct 29Sale344.495,0001,722,4500Nov 02 04:16 PM
Bancel StephaneChief Executive OfficerOct 28Sale343.7410,0003,437,4007,174,880Oct 29 04:36 PM
Andres JuanSee remarksOct 27Option Exercise12.215,00061,0505,000Oct 29 04:32 PM
Andres JuanSee remarksOct 27Sale344.255,0001,721,2500Oct 29 04:32 PM
Bancel StephaneChief Executive OfficerOct 27Sale344.259,0003,098,2506,022,868Oct 29 04:36 PM
Hoge StephenPresidentOct 25Option Exercise5.9520,000118,9001,629,597Oct 26 06:00 PM
Andres JuanSee remarksOct 25Option Exercise12.2315,000183,50815,000Oct 26 05:13 PM
Hoge StephenPresidentOct 25Sale331.8020,0006,636,0971,609,597Oct 26 06:00 PM
Andres JuanSee remarksOct 25Sale327.3615,0004,910,4000Oct 26 05:13 PM
Andres JuanSee remarksOct 22Option Exercise12.215,00061,0505,000Oct 26 05:13 PM
Andres JuanSee remarksOct 22Sale333.005,0001,665,0000Oct 26 05:13 PM
Bancel StephaneChief Executive OfficerOct 21Sale337.0010,0003,370,0007,184,880Oct 22 05:23 PM
Andres JuanSee remarksOct 20Option Exercise12.215,00061,0505,000Oct 22 05:39 PM
Bancel StephaneChief Executive OfficerOct 20Sale333.909,0003,005,1006,035,868Oct 22 05:23 PM
Andres JuanSee remarksOct 20Sale333.905,0001,669,5000Oct 22 05:39 PM
Andres JuanSee remarksOct 18Option Exercise12.215,00061,0505,000Oct 19 04:11 PM
Andres JuanSee remarksOct 18Sale322.265,0001,611,3000Oct 19 04:11 PM
Andres JuanSee remarksOct 15Option Exercise12.215,00061,0505,000Oct 19 04:11 PM
Andres JuanSee remarksOct 15Sale341.255,0001,706,2500Oct 19 04:11 PM
Bancel StephaneChief Executive OfficerOct 14Sale329.0010,0003,290,0007,194,880Oct 15 04:05 PM
Hoge StephenPresidentOct 13Option Exercise4.2915,00064,4001,624,597Oct 14 04:10 PM
Andres JuanSee remarksOct 13Option Exercise12.215,00061,0505,000Oct 14 04:21 PM
SAGAN PAULDirectorOct 13Sale314.902,250708,52514,951Oct 15 04:03 PM
Bancel StephaneChief Executive OfficerOct 13Sale314.909,0002,834,1006,048,868Oct 15 04:05 PM
Hoge StephenPresidentOct 13Sale314.9015,0004,723,5001,609,597Oct 14 04:10 PM
Andres JuanSee remarksOct 13Sale314.905,0001,574,5000Oct 14 04:21 PM
Hoge StephenPresidentOct 12Option Exercise10.905,00054,5001,614,597Oct 14 04:10 PM
Hoge StephenPresidentOct 12Sale313.225,0001,566,1001,609,597Oct 14 04:10 PM
Andres JuanSee remarksOct 11Option Exercise12.2115,000183,15015,000Oct 12 04:16 PM
Andres JuanSee remarksOct 11Sale300.0015,0004,500,0000Oct 12 04:16 PM
Andres JuanSee remarksOct 08Option Exercise12.215,00061,0505,000Oct 12 04:16 PM
Andres JuanSee remarksOct 08Sale310.445,0001,552,2000Oct 12 04:16 PM
Bancel StephaneChief Executive OfficerOct 07Sale295.0010,0002,950,0007,204,880Oct 08 04:14 PM
Andres JuanSee remarksOct 06Option Exercise12.215,00061,0505,000Oct 08 04:18 PM
Bancel StephaneChief Executive OfficerOct 06Sale318.239,0002,864,0706,061,868Oct 08 04:14 PM
Andres JuanSee remarksOct 06Sale318.235,0001,591,1500Oct 08 04:18 PM
Hoge StephenPresidentOct 04Option Exercise0.9920,00019,8001,629,597Oct 06 04:09 PM
Andres JuanSee remarksOct 04Option Exercise12.215,00061,0505,000Oct 05 04:12 PM
Hoge StephenPresidentOct 04Sale307.5420,0006,150,8001,609,597Oct 06 04:09 PM
Andres JuanSee remarksOct 04Sale307.545,0001,537,7000Oct 05 04:12 PM
Andres JuanSee remarksOct 01Option Exercise12.215,00061,0505,000Oct 05 04:12 PM
Andres JuanSee remarksOct 01Sale359.005,0001,795,0000Oct 05 04:12 PM
Bancel StephaneChief Executive OfficerSep 30Sale381.8210,0003,818,2007,214,880Oct 01 08:50 AM
Andres JuanSee remarksSep 29Option Exercise12.215,00061,0505,000Oct 01 08:53 AM
Bancel StephaneChief Executive OfficerSep 29Sale393.449,0003,540,9606,074,868Oct 01 08:50 AM
Andres JuanSee remarksSep 29Sale393.445,0001,967,2000Oct 01 08:53 AM
Andres JuanSee remarksSep 27Option Exercise12.2115,000183,15015,000Sep 28 04:22 PM
Andres JuanSee remarksSep 27Sale429.3815,0006,440,7000Sep 28 04:22 PM
Hoge StephenPresidentSep 24Option Exercise10.905,00054,5001,614,597Sep 27 04:11 PM
Andres JuanSee remarksSep 24Option Exercise12.215,00061,0505,000Sep 28 04:22 PM
Hoge StephenPresidentSep 24Sale448.045,0002,240,2001,609,597Sep 27 04:11 PM
Andres JuanSee remarksSep 24Sale448.045,0002,240,2000Sep 28 04:22 PM
Hoge StephenPresidentSep 23Option Exercise4.2915,00064,4001,624,597Sep 27 04:11 PM
Bancel StephaneChief Executive OfficerSep 23Sale439.4510,0004,394,5007,224,880Sep 24 04:17 PM
Hoge StephenPresidentSep 23Sale448.6015,0006,728,9391,609,597Sep 27 04:11 PM
Andres JuanSee remarksSep 22Option Exercise12.215,00061,0505,000Sep 24 04:09 PM
Andres JuanSee remarksSep 22Sale433.005,0002,165,0000Sep 24 04:09 PM
Bancel StephaneChief Executive OfficerSep 22Sale433.009,0003,897,0006,087,868Sep 24 04:17 PM
Andres JuanSee remarksSep 20Option Exercise12.215,00061,0505,000Sep 21 04:17 PM
Andres JuanSee remarksSep 20Sale417.625,0002,088,1000Sep 21 04:17 PM